Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke.

Published in: European journal of clinical pharmacology (2023)

This real-world study suggests that cilostazol is effective and safe for noncardioembolic ischemic stroke and may be associated with better effectiveness in hypertensive patients compared to clopidogrel.

Keyphrases

hypertensive patients
acute coronary syndrome
blood pressure
percutaneous coronary intervention
antiplatelet therapy
atrial fibrillation
randomized controlled trial
systematic review